Morrisville biotech raises $43.5M, earns key FDA status for polio-based cancer treatment
The company, which spun out of Duke University, has received investigational new drug status for its modified polio virus that targets cancer cells.
Source: bizjournals.com Health Care:Biotechnology headlines - Category: Biotechnology Authors: Sonia Waraich Source Type: news
More News: Biotechnology | Cancer | Cancer & Oncology | Health Management | Investigational New Drugs | Polio